Identification of new biomarkers of pyridoxine-dependent epilepsy by GC/MS-based urine metabolomics

被引:20
|
作者
Kuhara, Tomiko [1 ]
Akiyama, Tomoyuki [2 ]
Ohse, Morimasa [1 ]
Koike, Takayoshi [3 ]
Shibasaki, Jun [4 ]
Imai, Katsumi [3 ]
Cooper, Arthur J. L. [5 ]
机构
[1] Japan Clin Metabol Inst, Kahoku, Ishikawa 9291174, Japan
[2] Okayama Univ Hosp, Dept Child Neurol, Okayama 7008558, Japan
[3] NHO Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Dept Pediat, Shizuoka 4208688, Japan
[4] Kanagawa Childrens Med Ctr, Dept Neonatol, Yokohama, Kanagawa 2328555, Japan
[5] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA
关键词
Delta(2)-Piperideine-6-carboxylate; 6-Oxopipecolate; Metabolomics; Gas chromatography-mass spectrometry; Biomarker; Pipecolate; ALPHA-AMINOADIPIC SEMIALDEHYDE; L-PIPECOLATE OXIDASE; INBORN-ERRORS; ISOTOPE-DILUTION; 6-OXO-PIPERIDINE-2-CARBOXYLIC ACID; MASS-SPECTROMETRY; HUMAN-LIVER; DIAGNOSIS; DEFICIENCY; METABOLISM;
D O I
10.1016/j.ab.2020.113739
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Aminoadipic semialdehyde and its cyclic form (Delta(2)-piperideine-6-carboxylate) accumulate in patients with alpha-aminoadipic semialdehyde dehydrogenase (AASADH; antiquitin; ALDH7A1) deficiency. Delta(1) -Piperideine-6-carboxylate is known to react with pyridoxal 5'-phosphate (PLP) to form a Knoevenagel condensation product, resulting in pyridoxine-dependent epilepsy. Despite dramatic clinical improvement following pyridoxine supplementation, many patients still suffer some degree of intellectual disability due to delayed diagnosis. In order to expedite the diagnosis of patients with suspected AASADH deficiency and minimize the delay in treatment, we used gas chromatography-mass spectrometry-based metabolomics to search for potentially diagnostic biomarkers in urine from four patients with ALDH7A1 mutations, and identified Delta(2)-piperideine-6-carboxylate, 6-oxopipecolate, and pipecolate as candidate biomarkers. In a patient at postnatal day six, but before pyridoxine treatment, Delta(2)-piperideine-6-carboxylate and pipecolate were present at very high concentrations, indicating that these compounds may be good biomarkers for untreated AASADH deficiency patients. On the other hand, following pyridoxine/PLP treatment, 6-oxopipecolate was shown to be greatly elevated. We suggest that noninvasive urine metabolomics screening for Delta(2)-piperideine-6-carboxylate, 6-oxopipecolate, and pipecolate will be useful for prompt and reliable diagnosis of AASADH deficiency in patients within any age group. The most appropriate combination among Delta(2)-piperideine-6-carboxylate, 6-oxopipecolate, and pipecolate as biomarkers for AASADH deficiency patients appears to depend on the age of the patient and whether pyridoxine/PLP supplementation has been implemented. We anticipate that the present bioanalytical information will also be useful to researchers studying glutamate, proline, lysine and ornithine metabolism in mammals and other organisms.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Identification of odor biomarkers in irradiation injury urine based on headspace SPME-GC-MS
    Wu, Xin
    Zhu, Tong
    Zhang, Hongbing
    Lu, Lu
    He, Xin
    Liu, Changxiao
    Fan, Sai-jun
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2021, 97 (11) : 1597 - 1605
  • [32] GC/MS-based metabolomics detects metabolic alterations in serum from SLE patients
    Saegusa, J.
    Irino, Y.
    Yoshida, M.
    Tanaka, S.
    Kogata, Y.
    Kageyama, G.
    Tsuji, G.
    Takenawa, T.
    Kawano, S.
    Kumagai, S.
    Morinobu, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (01) : 148 - 148
  • [33] GC/MS-based metabolomics strategy to analyze the effect of exercise intervention in diabetic rats
    Li Jing
    Wang Chengji
    ENDOCRINE CONNECTIONS, 2019, 8 (06): : 654 - 660
  • [34] Identification of potential quality markers in Indonesia’s Arabica specialty coffee using GC/MS-based metabolomics approach
    Fitri Amalia
    Tomoya Irifune
    Tetsuji Takegami
    Ucu Yusianto
    Sastia Prama Sumirat
    Eiichiro Putri
    Metabolomics, 19
  • [35] GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort
    Ranjbar, Mohammad R. Nezami
    Luo, Yue
    Di Poto, Cristina
    Varghese, Rency S.
    Ferrarini, Alessia
    Zhang, Chi
    Sarhan, Naglaa I.
    Soliman, Hanan
    Tadesse, Mahlet G.
    Ziada, Dina H.
    Roy, Rabindra
    Ressom, Habtom W.
    PLOS ONE, 2015, 10 (06):
  • [36] Metabolic response of Scapharca subcrenata to heat stress using GC/MS-based metabolomics
    Jiang, Yazhou
    Jiao, Haifeng
    Sun, Peng
    Yin, Fei
    Tang, Baojun
    PEERJ, 2020, 8
  • [37] Early Identification of Serum Biomarkers and Pathways of Sepsis Through GC-MS-Based Metabolomics Analysis
    Chen, Cheng
    Meng, Xiaoxiao
    Zhu, Yong
    Zhang, Jiaxiang
    Wang, Ruilan
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (07):
  • [38] Determination of new biomarkers for diagnosis of pyridoxine dependent epilepsy in human plasma and urine by liquid chromatography-mass spectrometry
    Damiano, Roberta
    Della Bona, Maria
    Procopio, Elena
    Gasperini, Serena
    Guerrini, Renzo
    Bettiol, Alessandra
    la Marca, Giancarlo
    CLINICA CHIMICA ACTA, 2025, 567
  • [39] Identification of anthocyanins in the fruits of Kadsura coccinea using UPLC-MS/MS-based metabolomics
    Huang, Ding
    Ming, Ruhong
    Yao, Shaochang
    Li, Liangbo
    Huang, Rongshao
    Tan, Yong
    BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 2021, 98
  • [40] New insights into human lysine degradation pathways with relevance to pyridoxine-dependent epilepsy due to antiquitin deficiency
    Crowther, Lisa M.
    Mathis, Deborah
    Poms, Martin
    Plecko, Barbara
    JOURNAL OF INHERITED METABOLIC DISEASE, 2019, 42 (04) : 620 - 628